EL
Insider buying
Eric L. Keller bought $250K of Retension Pharmaceuticals, Inc. (RTSN) stock
Eric L. Keller, Chief Executive Officer of Retension Pharmaceuticals, Inc. (RTSN), bought 20,800 shares of RTSN stock worth $250K, per an SEC Form 4 filed Oct 13, 2026.
It was an open-market purchase.
The trade was reported on Oct 13, 2026.
- Traded
- Oct 13, 2026
- Disclosed
- Oct 13, 2026
- Filing delay
- 0 days
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More RTSN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.